These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16025837)

  • 101. Could trisialotransferrin be used as an additional biomarker to CDT in order to improve detection of chronic excessive alcohol intake?
    Tamigniau A; Wallemacq P; Maisin D
    Clin Biochem; 2014 Sep; 47(13-14):1203-8. PubMed ID: 24863961
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Use of laboratory markers and the audit questionnaire by primary care physicians to detect alcohol abuse by patients.
    Aalto M; Seppä K
    Alcohol Alcohol; 2005; 40(6):520-3. PubMed ID: 16215269
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Use of enzymes for the diagnosis of alcohol-related organ damage.
    Salaspuro M
    Enzyme; 1987; 37(1-2):87-107. PubMed ID: 2436906
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Utility of carbohydrate-deficient transferrin as a marker of relapse in alcoholic patients.
    Rosman AS; Basu P; Galvin K; Lieber CS
    Alcohol Clin Exp Res; 1995 Jun; 19(3):611-6. PubMed ID: 7573782
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Comparative performance of biomarkers of alcohol consumption in a population sample of working-aged men in Russia: the Izhevsk Family Study.
    McDonald H; Borinskya S; Kiryanov N; Gil A; Helander A; Leon DA
    Addiction; 2013 Sep; 108(9):1579-89. PubMed ID: 23692391
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Assessment of alcohol consumption by mailed questionnaire in epidemiological studies: evaluation of misclassification using a dietary history interview and biochemical markers.
    Carlsson S; Hammar N; Hakala P; Kaprio J; Marniemi J; Rönnemaa T
    Eur J Epidemiol; 2003; 18(6):493-501. PubMed ID: 12908714
    [TBL] [Abstract][Full Text] [Related]  

  • 107. New alcohol markers--how useful are they in population studies: the Svalbard Study 1988-89.
    Nilssen O; Huseby NE; Høyer G; Brenn T; Schirmer H; Førde OH
    Alcohol Clin Exp Res; 1992 Feb; 16(1):82-6. PubMed ID: 1348402
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Carbohydrate-deficient transferrin and gamma-glutamyl transpeptidase in the evaluation of alcohol consumption. A five-year retrospective study of 633 outpatients in a single center.
    Godart B; Mennetrey L; Schellenberg F; Pages JC; Bacq Y
    Gastroenterol Clin Biol; 2005 Feb; 29(2):113-6. PubMed ID: 15795656
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Serum level of carbohydrate-deficient transferrin as a marker of alcoholic liver disease.
    Yamauchi M; Hirakawa J; Maezawa Y; Nishikawa F; Mizuhara Y; Ohata M; Nakajima H; Toda G
    Alcohol Alcohol Suppl; 1993; 1B():3-8. PubMed ID: 8003126
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [A practical approach to the evaluation of excessive alcohol drinking].
    Cambou JP
    Ann Cardiol Angeiol (Paris); 2002 Dec; 51(6):321-6. PubMed ID: 12608123
    [TBL] [Abstract][Full Text] [Related]  

  • 111. How strong is the evidence for using blood biomarkers alone to screen for alcohol consumption during pregnancy? A systematic review.
    Howlett H; Abernethy S; Brown NW; Rankin J; Gray WK
    Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():45-52. PubMed ID: 28426943
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Use of serum carbohydrate-deficient transferrin values to exclude alcoholic hepatitis from non-alcoholic steatohepatitis: a pilot study.
    Ohtsuka T; Tsutsumi M; Fukumura A; Tsuchishima M; Takase S
    Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):236S-9S. PubMed ID: 16385229
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Carbohydrate-deficient transferrin: diagnostic efficiency among patients with end-stage liver disease before and after liver transplantation.
    Heinemann A; Sterneck M; Kuhlencordt R; Rogiers X; Schulz KH; Queen B; Wischhusen F; Püschel K
    Alcohol Clin Exp Res; 1998 Nov; 22(8):1806-12. PubMed ID: 9835300
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Traditional markers of excessive alcohol use.
    Conigrave KM; Davies P; Haber P; Whitfield JB
    Addiction; 2003 Dec; 98 Suppl 2():31-43. PubMed ID: 14984240
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Carbohydrate-deficient transferrin: validity of a new alcohol biomarker in a sample of patients with diabetes and hypertension.
    Fleming M; Mundt M
    J Am Board Fam Pract; 2004; 17(4):247-55. PubMed ID: 15243012
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Plasma sialic-acid index of apolipoprotein J (SIJ): a new alcohol intake marker.
    Ghosh P; Hale EA; Lakshman MR
    Alcohol; 2001 Nov; 25(3):173-9. PubMed ID: 11839462
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Comparison of serum calprotectin, a marker of neutrophil activation, and other mediators of inflammation in response to alcohol consumption.
    Nivukoski U; Bloigu A; Bloigu R; Kultti J; Tuomi H; Niemelä O
    Alcohol; 2021 Sep; 95():45-50. PubMed ID: 34228990
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Serum beta-hexosaminidase as a marker of heavy drinking.
    Kärkkäinen P; Poikolainen K; Salaspuro M
    Alcohol Clin Exp Res; 1990 Apr; 14(2):187-90. PubMed ID: 1972003
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Analysis of carbohydrate-deficient transferrin (CDT) in vitreous humour as a forensic tool for detection of alcohol misuse.
    Berkowicz A; Wallerstedt S; Wall K; Denison H
    Forensic Sci Int; 2003 Nov; 137(2-3):119-24. PubMed ID: 14609646
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Biomarkers demonstrate increased consumption, but not abuse, of ethanol in essential tremor.
    Ulmanová O; Vinopalová M; Zima T; Růžička E
    J Neurol; 2012 Jun; 259(6):1177-80. PubMed ID: 22146903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.